<DOC>
	<DOCNO>NCT02087423</DOCNO>
	<brief_summary>A study assess Effects MEDI4736 Patients With Locally Advanced Metastatic Non Small Cell Lung Cancer term efficacy , safety tolerability</brief_summary>
	<brief_title>A Global Study Assess Effects MEDI4736 Patients With Locally Advanced Metastatic Non Small Cell Lung Cancer</brief_title>
	<detailed_description>This study design investigate efficacy , safety , tolerability new drug , MEDI4736 , patient Locally Advanced Metastatic Non Small Cell Lung Cancer . MEDI4736 investigate patient receive least two prior treatment regimen include one platinum-based chemotherapy</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Antibodies , Monoclonal</mesh_term>
	<criteria>Aged least 18 year . Documented evidence NSCLC ( stage IIIB/IV disease ) Disease progression recurrence platinumbased chemotherapy least 1 additional regimen treatment NSCLC World Health Organisation ( WHO ) Performance Status 0 1 Estimated life expectancy 12 week Patient 's tumour sample must PDL1 positive ( ≥25 % tumour cell membrane staining ( Cohort 1 2 ) PDL1 positive ≥90 % tumour cell membrane staining ( Cohort 3 ) ) Prior exposure antiPD1 antiPDL1 antibody Brain metastases spinal cord compression unless asymptomatic , treat stable ( require steroid ) . Active prior autoimmune disease history immunodeficiency Evidence severe uncontrolled systemic disease , include active bleeding diatheses active infection include hepatitis B , C HIV . Evidence uncontrolled illness symptomatic congestive heart failure , uncontrolled hypertension unstable angina pectoris . Any unresolved toxicity CTCAE &gt; Grade 2 previous anticancer therapy . Any prior Grade ≥3 immunerelated adverse event ( irAE ) receive previous immunotherapy agent , unresolved irAE &gt; Grade 1 Active prior document inflammatory bowel disease ( eg , Crohn 's disease , ulcerative colitis )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>130 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Locally advanced , metastatic , Non-Small Cell Lung Cancer , MEDI4736 , PD-L1</keyword>
</DOC>